<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JBA</journal-id>
<journal-id journal-id-type="hwp">spjba</journal-id>
<journal-id journal-id-type="nlm-ta">J Biomater Appl</journal-id>
<journal-title>Journal of Biomaterials Applications</journal-title>
<issn pub-type="ppub">0885-3282</issn>
<issn pub-type="epub">1530-8022</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0885328212448259</article-id>
<article-id pub-id-type="publisher-id">10.1177_0885328212448259</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Platelet adhesion and human umbilical vein endothelial cell cytocompatibility of biodegradable segmented polyurethanes prepared with 4,4′-methylene bis(cyclohexyl isocyanate), poly(caprolactone) diol and butanediol or dithioerythritol as chain extenders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chan-Chan</surname><given-names>LH</given-names></name>
<xref ref-type="aff" rid="aff1-0885328212448259">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vargas-Coronado</surname><given-names>RF</given-names></name>
<xref ref-type="aff" rid="aff1-0885328212448259">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cervantes-Uc</surname><given-names>JM</given-names></name>
<xref ref-type="aff" rid="aff1-0885328212448259">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cauich-Rodríguez</surname><given-names>JV</given-names></name>
<xref ref-type="aff" rid="aff1-0885328212448259">1</xref>
<xref ref-type="corresp" rid="corresp1-0885328212448259"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Rath</surname><given-names>R</given-names></name>
<xref ref-type="aff" rid="aff2-0885328212448259">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Phelps</surname><given-names>EA</given-names></name>
<xref ref-type="aff" rid="aff2-0885328212448259">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>García</surname><given-names>AJ</given-names></name>
<xref ref-type="aff" rid="aff2-0885328212448259">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>del Barrio</surname><given-names>J San Román</given-names></name>
<xref ref-type="aff" rid="aff3-0885328212448259">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Parra</surname><given-names>J</given-names></name>
<xref ref-type="aff" rid="aff4-0885328212448259">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Merhi</surname><given-names>Y</given-names></name>
<xref ref-type="aff" rid="aff5-0885328212448259">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tabrizian</surname><given-names>M</given-names></name>
<xref ref-type="aff" rid="aff6-0885328212448259">6</xref>
</contrib>
</contrib-group>
<aff id="aff1-0885328212448259"><label>1</label>Centro de Investigación Científica de Yucatán, A.C., Calle 43 # 130 Col. Chuburná de Hidalgo, Mérida, Yucatán, México</aff>
<aff id="aff2-0885328212448259"><label>2</label>Woodruff School of Mechanical Engineering, Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, USA</aff>
<aff id="aff3-0885328212448259"><label>3</label>Instituto de Ciencia y Tecnología de Polímeros, Juan de la Cierva 3, Madrid, Spain</aff>
<aff id="aff4-0885328212448259"><label>4</label>Associated Unity CAA-CSIC, Hospital Provincial, Complejo Asistencial de Ávila, SACYL, Jesús del Gran Poder 42. 05003 Ávila, Spain</aff>
<aff id="aff5-0885328212448259"><label>5</label>Montreal Heart Institute, Laboratory of Thrombosis and Hemostasis, Montreal, QC, Canada</aff>
<aff id="aff6-0885328212448259"><label>6</label>Department of Biomedical Engineering &amp; Faculty of Dentistry, Montreal, QC, Canada</aff>
<author-notes>
<corresp id="corresp1-0885328212448259">JV Cauich-Rodríguez, Centro de Investigación Científica de Yucatán, A.C., Calle 43 # 130 Col. Chuburná de Hidalgo, Mérida, Yucatán, México. Email: <email>jvcr@cicy.mx</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>2</issue>
<fpage>270</fpage>
<lpage>277</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Biodegradable segmented polyurethanes were prepared with poly(caprolactone) diol as a soft segment, 4,4′-methylene bis(cyclohexyl isocyanate) (HMDI) and either butanediol or dithioerythritol as chain extenders. Platelet adhesion was similar in all segmented polyurethanes studied and not different from Tecoflex® although an early stage of activation was observed on biodegradable segmented polyurethane prepared with dithioerythritol. Relative viability was higher than 80% on human umbilical vein endothelial cells in contact with biodegradable segmented polyurethane extracts after 1, 2 and 7 days. Furthermore, both biodegradable segmented polyurethane materials supported human umbilical vein endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. These biodegradable segmented polyurethanes represent promising materials for cardiovascular applications.</p>
</abstract>
<kwd-group>
<kwd>Segmented polyurethanes</kwd>
<kwd>cardiovascular</kwd>
<kwd>hemocompatibility</kwd>
<kwd>cell adhesion</kwd>
<kwd>thiol chain extender</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0885328212448259" sec-type="intro"><title>Introduction</title>
<p>The various applications of segmented polyurethanes (SPUs) in the biomaterials field are generally associated with their good physicochemical and mechanical properties while exhibiting an acceptable biological performance. Traditionally, SPUs have been used in cardiovascular applications as permanent devices such as pacemaker leads and ventricular assisting devices.<sup><xref ref-type="bibr" rid="bibr1-0885328212448259">1</xref></sup> However, due to their great chemistry versatility, SPUs can also be tailored to render biodegradable systems for the tissue engineering of vascular grafts and heart valves.<sup><xref ref-type="bibr" rid="bibr2-0885328212448259">2</xref>,<xref ref-type="bibr" rid="bibr3-0885328212448259">3</xref></sup> For tissue engineering purposes, biodegradable SPUs can be prepared following two approaches, using either biodegradable soft segments or biodegradable rigid segments. In the first case, polyester polyurethanes such as those containing poly(caprolactone) diol (PCL) have been prepared<sup><xref ref-type="bibr" rid="bibr4-0885328212448259">4</xref>,<xref ref-type="bibr" rid="bibr5-0885328212448259">5</xref></sup> along with poly(lactic acid),<sup><xref ref-type="bibr" rid="bibr6-0885328212448259">6</xref></sup> poly(ethylene oxide)<sup><xref ref-type="bibr" rid="bibr7-0885328212448259">7</xref>,<xref ref-type="bibr" rid="bibr8-0885328212448259">8</xref></sup> and poly(3-hydroxybutyrate diol)<sup><xref ref-type="bibr" rid="bibr9-0885328212448259">9</xref></sup> based SPUs. On the other hand, as the rigid segment is formed by the diisocyanate and the chain extender, it provides as well two possibilities to prepare biodegradable polyurethanes. The diisocyanate can be modified or the chain extender can be selected from a variety of biologically relevant molecules. As such, SPUs with biodegradable rigid segments have been prepared with aliphatic diisocyanates such as 1,4-butanediisocyanate (BDI),<sup><xref ref-type="bibr" rid="bibr4-0885328212448259">4</xref></sup> ethyl lysine diisocyanate (ELDI),<sup><xref ref-type="bibr" rid="bibr5-0885328212448259">5</xref></sup> hexamethylene diisocyanate (HDI)<sup><xref ref-type="bibr" rid="bibr10-0885328212448259">10</xref></sup> and methyl lysine diisocyanate (MLDI).<sup><xref ref-type="bibr" rid="bibr11-0885328212448259">11</xref></sup> In terms of the chain extender, various amino acids<sup><xref ref-type="bibr" rid="bibr11-0885328212448259">11</xref><xref ref-type="bibr" rid="bibr12-0885328212448259"/><xref ref-type="bibr" rid="bibr13-0885328212448259"/><xref ref-type="bibr" rid="bibr14-0885328212448259"/>–<xref ref-type="bibr" rid="bibr15-0885328212448259">15</xref></sup> and other low molecular weight compounds with a specific functionality or activity have been used.<sup><xref ref-type="bibr" rid="bibr16-0885328212448259">16</xref></sup></p>
<p>In spite of the tailored properties obtained through the aforementioned multiple choices for their synthesis which provide them with good mechanical (tensile) strength and acceptable biocompatibility, the biodegradable SPUs suffer from poor fatigue properties and uncontrollable degradation rates. Therefore, current research in biomedical polyurethanes has focused on improving biocompatibility and controlled degradation rates. In designing biocompatible biodegradable SPUs, in general, aliphatic diisocyanates are chosen because, once incorporated into the polymer, their degradation products (i.e. the corresponding diamine) are not toxic. Polyesters such as PCL are also preferred as they can be hydrolytically and enzymatically degraded with caproic acid as a by-product. Finally, the chain extender can be selected from compounds that possess hydrolytically labile linkages.</p>
<p>In the present work, we investigated platelet adhesion to and HUVEC’s cytocompatibility of biodegradable segmented polyurethanes (BSPU) prepared with 4,4′-methylene bis(cyclohexyl isocyanate) (HMDI), an aliphatic diisocyanate, PCL, a commonly used polyester and, either butanediol (BD) or dithioerythritol (DTE) as chain extenders for potential cardiovascular applications. BD was selected because it is a common chain extender used in commercial formulations whereas DTE was chosen on the basis of its nitric oxide release potential due to exchange reactions between the thiol groups on DTE and S-nitroso albumins that circulate in the blood.</p>
</sec>
<sec id="sec2-0885328212448259" sec-type="materials|methods"><title>Materials and methods</title>
<sec id="sec3-0885328212448259"><title>Polyurethane synthesis</title>
<p>BSPUs with a molar ratio of 2.05:1:1 (HMDI:BD or DTE:PCL) were synthesized as previously reported.<sup><xref ref-type="bibr" rid="bibr17-0885328212448259">17</xref></sup> Briefly, diol-terminated poly(caprolactone) was mixed, in a glass reactor at 60℃ under nitrogen atmosphere, with a molar excess of 4,4′-methylene bis (cyclohexyl isocyanate) in the presence of 0.15 wt% stannous octoate and DMF in order to form a NCO-terminated prepolymer. In the second stage, either butanediol or dithioerythritol was used as extender to form the hard segments (referred to as BSPU1 and BSPU2, respectively). The reaction time for the prepolymer formation was 4 h at 60℃ while the second stage lasted 2 h. After this time, the polymer was precipitated and washed with distilled water and then dried at 60℃. In previous studies it was observed that this procedure was enough to purify the polymer as no <sup>1</sup>H RMN signal from either HMDI or DMF were detected. Polymer yield was superior to 90%. <xref ref-type="fig" rid="fig1-0885328212448259">Figure 1</xref> shows the proposed structure for these segmented polyurethanes. The physicochemical and mechanical properties of these segmented polyurethanes have been previously reported.<sup><xref ref-type="bibr" rid="bibr17-0885328212448259">17</xref></sup>
<fig id="fig1-0885328212448259" position="float"><label>Figure 1.</label><caption><p>Chemical structure of biodegradable segmented polyurethenes. (a) BSPU1 and (b) BSPU2.</p><p>BSPU: biodegradable segmented polyurethanes.</p>
</caption><graphic xlink:href="10.1177_0885328212448259-fig1.tif"/></fig>
</p>
</sec>
<sec id="sec4-0885328212448259"><title>Platelet adhesion</title>
<p>The protocol followed for labeling platelets was reported by Poussard et al.<sup><xref ref-type="bibr" rid="bibr18-0885328212448259">18</xref></sup> Briefly, 8 mm diameter non-sterile polymer discs obtained with a punch were placed in a 24-well plate and flooded with 500 µL of radiolabel platelet-rich plasma (250 × 10<sup>6</sup> platelets/mL) at room temperature (23℃) and then shaken for 1 h. After 1 h, samples were removed, rinsed carefully with NaCl solution and fixed in formalin solution. The platelets were quantified, using a 1470 Wizard (Wallac) Gamma counter adjusted at 360–480 keV. After the experiment, samples were kept for 1 week, then dehydrated gradually by immersion in ethanol: water mixtures (30:70, 50:50, 70:30, 80:20, 90:10, 95:5 and 100:0), critical point dried with CO<sub>2</sub> liquid as transitional fluid medium and sputter coated with gold. They were then examined using a Jeol 6310 LV scanning electron microscope.</p>
</sec>
<sec id="sec5-0885328212448259"><title>Cytotoxicity of eluted products by MTT assay</title>
<p>BSPU and Tecoflex extracts were tested for cytotoxicity via the MTT assay after conditioning in culture media. For this, discs (14 mm in diameter) were sterilized with ethylene oxide and then washed two times with phosphate buffer saline (PBS). Polyurethanes were incubated in serum-free culture media (5 mL) at 37℃ for 1, 2 and 7 days under constant agitation. After incubation time, media was recovered and frozen at −20℃, and replaced with 5 mL of fresh culture media except for the last day. Media incubated in Thermanox® tissue culture disks (13 mm diameter, non-toxic) and media supplemented with 1% Triton X-100 (toxic) were used as negative and positive controls for cytotoxicity.</p>
<p>Human umbilical vein endothelial cells (HUVEC, Pharmakine) were seeded in complete culture media in 96-well plates (10<sup>4</sup> cells/well) and cultured for 24 h at 37℃ with 5% CO<sub>2</sub> atmosphere. After this time, culture media was replaced with the extracts and incubated for an additional 24 h at 37℃ and 5% CO<sub>2</sub> atmosphere. After this second incubation period, the content of the wells was removed and the MTT reagent (0.5 mg/mL; Sigma) added and then 100 µL of dimethyl sulfoxide (DMSO; Sharlau). Wells were read at 570 nm, with a reference of 630 nm, using a Biotek ELX808IU spectrometer. The absorbance of the blank was subtracted from the absorbance values obtained from the samples and then normalized with respect to the absorbance values of the negative control (Thermanox). In this way, relative cell viability was obtained with respect to the control (%VR) using the following formula:
<disp-formula id="disp-formula1-0885328212448259"><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="math1-0885328212448259"><mml:mrow><mml:mi>%</mml:mi><mml:mtext>VR</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>DO</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>DO</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>DO</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>DO</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic alternate-form-of="disp-formula1-0885328212448259" xlink:href="10.1177_0885328212448259-eq1.tif"/></disp-formula>
where, <italic>DO<sub>S</sub></italic>, <italic>DO<sub>B</sub></italic> and <italic>DO<sub>C</sub></italic> are the optical densities of the sample, blank (MMT in culture media without cells) and the negative control, respectively.</p>
</sec>
<sec id="sec6-0885328212448259"><title>Biocompatibility of films in direct contact with HUVECs</title>
<sec id="sec7-0885328212448259"><title>Cell culture</title>
<p>HUVEC from Lonza were used for direct-culture cytocompatibility studies. Cells were cultured in EGM-2 media (Lonza) supplemented with 10% fetal bovine serum (Gibco), 1% v/v glutamine (200 mM; Sigma), gentamicin (40 µg/mL; Sigma), 1% penicillin–streptomycin (10,000 U/mL penicilin, 10 mg/mL streptomicin; Sigma), pituitary bovine extract (0.5% v/v; Sigma), endothelial growth factor (1% v/v; Sigma) and hydrocortisone (0.5 mg/mL; Sigma) at 37℃ and 5% CO<sub>2</sub>. Cells were passaged using standard conditions and cultures between passages 4 and 12 were used.</p>
</sec>
<sec id="sec8-0885328212448259"><title>Live/dead assay</title>
<p>Discs were cut out from BSPU1, BSPU2, and Tecoflex with an 8 mm biopsy punch. The disk samples were washed overnight in PBS with agitation followed by two additional 1 h washes. The samples were adhered to the bottom of 48-well plate with a dab of sterile silicon vacuum grease and sterilized by exposure to a UV germicidal lamp for 1 h. HUVECs were seeded onto the materials in EGM-2 media at 30,000 cells/cm<sup>2</sup>. HUVECs were allowed to adhere to materials for 24 h and then were stained with 4 mM Calcein-AM and 4 mM ethidium homodimer-1 (Invitrogen Live/Dead® Viability/Cytotoxicity Kit) in PBS for 20 min at 37℃. Stained cells on the materials were imaged with laser confocal scanning microscopy at excitation/emission wavelengths of 488/525 nm and 561/595 nm. The samples were then transferred to fresh wells and trypsinized. The recovered cells were pooled and resuspended in 500 µL of PBS. HUVEC samples were analyzed on an Accuri C6 Flow Cytometer. At least 4000 events were counted and cells were gated for live and dead fractions in each sample (corresponding to Calcein-AM and ethidium homodimer-1 fluorescence). A positive control of HUVEC grown on tissue culture plastic treated with Calcein-AM only, and negative control of HUVEC permeabilized with 1% Triton-X 100 and stained with ethidium homodimer only were used to setup live/dead gating parameters.</p>
</sec>
<sec id="sec9-0885328212448259"><title>Statistical analysis</title>
<p>Statistical analysis was performed to asses differences in the measured properties by one-way analysis of variance at a significance level <italic>p</italic> &lt; 0.05 using Microcal Origin. Flow cytometry histograms were analyzed by the Kruskal–Wallis non-parametric test.</p>
</sec>
</sec>
</sec>
<sec id="sec10-0885328212448259" sec-type="results"><title>Results</title>
<sec id="sec11-0885328212448259"><title>Platelet adhesion</title>
<p>Both platelet adhesion (<xref ref-type="fig" rid="fig2-0885328212448259">Figure 2</xref>) and scanning electron microscopy (SEM) image analysis (<xref ref-type="fig" rid="fig3-0885328212448259">Figure 3</xref>) showed that our segmented polyurethanes and Tecoflex used as control samples had very similar behavior. In general, on both samples platelets exhibited a non-rounded shape (see insert in <xref ref-type="fig" rid="fig3-0885328212448259">Figure 3</xref>), either dendritic or discoid (2–3 µm), with pseudopodia extensions suggesting early stages of activation.
<fig id="fig2-0885328212448259" position="float"><label>Figure 2.</label><caption><p>Platelet adhesion on BSPU1, BSPU2 and Tecoflex®.</p><p>BSPU: biodegradable segmented polyurethanes.</p></caption><graphic xlink:href="10.1177_0885328212448259-fig2.tif"/></fig>
<fig id="fig3-0885328212448259" position="float"><label>Figure 3.</label><caption><p>SEM micrographs of platelets adhered to (a) BSPU1, (b) BSPU2 and (c) Tecoflex®.</p>
<p>SEM: scanning electron microscopy; BSPU: biodegradable segmented polyurethanes.</p></caption><graphic xlink:href="10.1177_0885328212448259-fig3.tif"/></fig>
</p>
</sec>
<sec id="sec12-0885328212448259"><title>Cytocompatibility of BSPU eluants</title>
<p>Cells growing on tissue culture polystyrene were exposed to serum-free media incubated in BSPU substrates to evaluate whether any products released from the polymers influenced cellular activities. The metabolic activity of HUVECs, as determined by the MTT assay, cultured in media pre-incubated in BSPU1 and BSPU2 substrates remained high and equivalent to cells exposed to media pre-incubated in Thermanox® cell culture substrates (<xref ref-type="fig" rid="fig4-0885328212448259">Figure 4</xref>). Furthermore, there were no differences in metabolic activity for BSPU substrates as a function of pre-incubation time.
<fig id="fig4-0885328212448259" position="float"><label>Figure 4.</label><caption><p>Cytotoxicity of BSPU extracts on HUVEC metabolic by means of the MTT assay. Values were normalized to Thermanox® reference.</p><p>BSPU: biodegradable segmented polyurethanes; HUVEC: human umbilical vein endothelial cell.</p></caption><graphic xlink:href="10.1177_0885328212448259-fig4.tif"/></fig></p>
</sec>
<sec id="sec13-0885328212448259"><title>Cell adhesion, spreading and viability</title>
<p>For the live/dead assay, live cells incorporate Calcein-AM and stain green, whereas dead cells are permeable to ethidium homodimer and stain red. Microscopic analysis of cultured cells on BSPUs and Tecoflex® surfaces at 24 h in culture demonstrated high cell viability on all surfaces, although less live cells were present on BSPU2 (<xref ref-type="fig" rid="fig5-0885328212448259">Figure 5</xref>). In addition, HUVECs were well adhered and spread onto BSPUs, with more cell spreading on BSPU1 (<italic>p</italic> &lt; 0.05) compared to BSPU2 (<xref ref-type="fig" rid="fig6-0885328212448259">Figure 6</xref>). Cells on Tecoflex® substrate remained rounded.
<fig id="fig5-0885328212448259" position="float"><label>Figure 5.</label><caption><p>Live/dead staining for HUVEC cultured on substrates.</p><p>HUVEC: human umbilical vein endothelial cell.</p></caption><graphic xlink:href="10.1177_0885328212448259-fig5.tif"/></fig>
<fig id="fig6-0885328212448259" position="float"><label>Figure 6.</label><caption><p>Cell spreading area for HUVEC cultured on BSPU1, BSPU2 and Tecoflex® polyurethanes.</p><p>BSPU: biodegradable segmented polyurethanes; HUVEC: human umbilical vein endothelial cell.</p></caption><graphic xlink:href="10.1177_0885328212448259-fig6.tif"/></fig>
</p>
<p>Cells were recovered and analyzed for live/dead staining by flow cytometry. <xref ref-type="fig" rid="fig7-0885328212448259">Figure 7</xref> presents histograms demonstrating high cell viability among polyurethane substrates. Cell viability was higher on BSPU1 compared to BSPU2 (<italic>p</italic> &lt; 0.01) and there were no differences between BSPU1 and Tecoflex®.
<fig id="fig7-0885328212448259" position="float"><label>Figure 7.</label><caption><p>Flow cytometry histograms for live (top) and dead (cells) cultured on polyurethanes. Vertical lines show gates for analysis.</p></caption><graphic xlink:href="10.1177_0885328212448259-fig7.tif"/>
</fig></p>
</sec>
</sec>
<sec id="sec14-0885328212448259" sec-type="discussion"><title>Discussion</title>
<p>In a previous study, we demonstrated that BSPUs prepared with HMDI, PCL and butanediol or dithioerythritol as chain extenders exhibited good physicochemical and mechanical properties.<sup><xref ref-type="bibr" rid="bibr17-0885328212448259">17</xref></sup> However, for cardiovascular applications their behavior in contact with whole blood, plasma or endothelial cells needs to be assessed in order to prevent thrombus formation. In this regard, platelet adhesion to BSPU1 and BSPU2 showed a similar behavior to Tecoflex®. In all cases, the fraction of platelets adhered compared to the seeded platelets was 0.22%, 0.27% and 0.18% for Tecoflex, BSPU1 and BSPU2, respectively.</p>
<p>In spite of being non-rounded, adherent platelets did not reach full activation in all cases studied as the fully spread morphology (7–10 µm) was never attained. A proper comparison with other polyurethanes is difficult to make as there are many variables involved like number of cells seeded and donor variations. For example, Poussard et al.<sup><xref ref-type="bibr" rid="bibr18-0885328212448259">18</xref></sup> reported that a thrombogenic surface was formed when the number of platelets adhered/cm<sup>2</sup> reached 5 × 10<sup>5</sup> which is similar to the number of cell attached in our samples. These preliminary results on platelet adhesion, however, need further studies such conformational changes in the GPIIb/IIIa glycoproteins to verify their activation process. In addition, longer times than 1 h used in our study might show the full activation process if occurring.</p>
<p>In agreement with these results we have reported that the values for activated partial thromboplastin time (APTT) and prothrombin time (PT) determined with citrated plasma were also similar for BSPU1, BSPU2 and Tecoflex® (BSPU1: APTT = 33.0 ± 1.8 s, PT = 15.6 ± 1.3 s; BSPU2: APTT = 29.5 ± 1.7 s, PT =13.4 ± 2.0 s; Tecoflex®: APTT = 31.6 ± 4.9 s, PT = 14.2 ± 1.6).<sup><xref ref-type="bibr" rid="bibr17-0885328212448259">17</xref></sup> Taking all these results together it is concluded that the presence of thiol groups in the DTE used for the synthesis of BSPU2 does not inhibit coagulation cascade as it has been reported in similar materials.<sup><xref ref-type="bibr" rid="bibr19-0885328212448259">19</xref>,<xref ref-type="bibr" rid="bibr20-0885328212448259">20</xref></sup> One possible explanation is SH rapid oxidation in air forming disulfide bonds.</p>
<p>The use of endothelials cell for pre-lining PTFE and Dacron has been suggested as a mean to improve hemocompatibility of vascular grafts. However, the use of endothelial cells on SPU is not common as the cells are not capable of proliferating to confluence or exhibiting strong adhesion to the surface.<sup><xref ref-type="bibr" rid="bibr21-0885328212448259">21</xref></sup> Improved cell adhesion and spreading are critical requirements for endothelization of vascular grafts, and this can be achieved through surface modification such as ion radiation (N, O and Ar),<sup><xref ref-type="bibr" rid="bibr22-0885328212448259">22</xref></sup> RGD cell-adhesive oligopeptide grafting,<sup><xref ref-type="bibr" rid="bibr23-0885328212448259">23</xref><xref ref-type="bibr" rid="bibr24-0885328212448259"/>–<xref ref-type="bibr" rid="bibr25-0885328212448259">25</xref></sup> low molecular weight hyaluronic acid grafting<sup><xref ref-type="bibr" rid="bibr26-0885328212448259">26</xref></sup> or even by increasing surface roughness<sup><xref ref-type="bibr" rid="bibr27-0885328212448259">27</xref></sup> to name a few.</p>
<p>According to our MTT results, either BSPU1 or BSPU2 did not release sufficient levels of toxic leachables that could negatively affect endothelial cell colonization and activities. In our study, we also observed that the BSPU substrates supported higher (BSPU1) or equivalent (BSPU2) levels of HUVECs adhesion, spreading and viability at 24 h compared to the commonly used Tecoflex® polyurethane without further surface modification. Contact angles for BSPU1 and BSPU2 were 72° ± 3.5 and 62° ± 0.5 respectively, suggesting that a more hydrophobic materials suited cell attachment. Even when cell attachment was relatively low compared to control spreading as demonstrated by the live/dead assay this was also confirmed by SEM after 48 h (data not shown). For BSPU1, even when a higher degree of endothelization was reached, this is not a guarantee of a functional endothelium and specific markers such as vWF, VE-Cadherins and eNOS need to be quantified.</p>
<p>Taken together, the present study demonstrates that PCL-based BSPU with butanediol and dithioerythritol as chain extenders exhibit similar hemo- and cytocompatibility compared to Tecoflex® polyurethanes. These polymers warrant further analysis as degradable materials for cardiovascular applications.</p>
</sec>
<sec id="sec15-0885328212448259" sec-type="conclusions"><title>Conclusion</title>
<p>BSPUs, prepared with poly(caprolactone) as a soft segment, 4,4′-methylene bis (cyclohexyl isocyanate) and either butanediol or dithioerythritol as chain extenders, were non-cytotoxic and supported human endothelial cell adhesion, spreading, and viability similar to Tecoflex® medical-grade polyurethane. Furthermore, these polymers exhibited low levels of platelet adhesion similar to hemocompatible materials. These BSPUs represent promising materials for cardiovascular applications.</p>
</sec>
</body>
<back>
<sec id="sec16-0885328212448259"><title>Funding</title>
<p>▪▪▪</p>
<p>This work was supported by CONACYT (México) grant SEP-2003-CO2-43175. R. Rath was supported by a Presidential Undergraduate Research Award from the Georgia Institute of Technology. The authors also wish to thank AECI for supporting this program. The authors also acknowledge the Ministère des relations internationals du Québec for funding the exchange program between Mexico and Québec and Dr Cathy Tkaczyk for her advices in platelet adhesion studies.</p>
</sec>
<ref-list><title>References</title>
<ref id="bibr1-0885328212448259"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zdrahala</surname><given-names>RJ</given-names></name><name><surname>Zdrahala</surname><given-names>IJ</given-names></name></person-group>. <article-title>Biomedical applications of polyurethanes: a review of past promises, present realities, and a vibrant future</article-title>. <source>J Biomater Appl</source> <year>1999</year>; <volume>14</volume>(<issue>1</issue>): <fpage>67</fpage>–<lpage>90</lpage>.</citation></ref>
<ref id="bibr2-0885328212448259"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>C</given-names></name><name><surname>Cassano</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Endothelial cell seeding of a 4-mm I.D. polyurethane vascular graft</article-title>. <source>J Biomater Appl</source> <year>2002</year>; <volume>17</volume>(<issue>1</issue>): <fpage>45</fpage>–<lpage>70</lpage>.</citation></ref>
<ref id="bibr3-0885328212448259"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grenier</surname><given-names>S</given-names></name><name><surname>Sandig</surname><given-names>M</given-names></name><name><surname>Holdsworth</surname><given-names>DW</given-names></name><etal/></person-group>. <article-title>Interactions of coronary artery smooth muscle cells with 3D porous polyurethane scaffolds</article-title>. <source>J Biomed Mater Res</source> <year>2009</year>; <volume>89A</volume>(<issue>2</issue>): <fpage>293</fpage>–<lpage>303</lpage>.</citation></ref>
<ref id="bibr4-0885328212448259"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heijkants</surname><given-names>RGJC</given-names></name><name><surname>van Calck</surname><given-names>RV</given-names></name><name><surname>van Tienen</surname><given-names>TG</given-names></name><etal/></person-group>. <article-title>Uncatalyzed synthesis, thermal and mechanical properties of polyurethanes based on poly(-caprolactone) and 1,4-butane diisocyanate with uniform hard segment</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>(<issue>20</issue>): <fpage>4219</fpage>–<lpage>4228</lpage>.</citation></ref>
<ref id="bibr5-0885328212448259"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>MK</given-names></name><name><surname>Mauritz</surname><given-names>KA</given-names></name><name><surname>Storey</surname><given-names>RF</given-names></name><etal/></person-group>. <article-title>Biodegradable aliphatic thermoplastic polyurethane based on poly(ɛ-caprolactone) and L-lysine diisocyanate</article-title>. <source>J Polym Sci Part A: Polym Chem</source> <year>2006</year>; <volume>44</volume>(<issue>9</issue>): <fpage>2990</fpage>–<lpage>3000</lpage>.</citation></ref>
<ref id="bibr6-0885328212448259"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Izhar</surname><given-names>U</given-names></name><name><surname>Schwalb</surname><given-names>H</given-names></name><name><surname>Borman</surname><given-names>JB</given-names></name><etal/></person-group>. <article-title>Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study</article-title>. <source>J Surg Res</source> <year>2001</year>; <volume>95</volume>(<issue>2</issue>): <fpage>152</fpage>–<lpage>160</lpage>.</citation></ref>
<ref id="bibr7-0885328212448259"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gorna</surname><given-names>K</given-names></name><name><surname>Gogolewski</surname><given-names>S</given-names></name></person-group>. <article-title>Biodegradable polyurethanes for implants. II. In vitro degradation and calcification of materials from poly(ɛ-caprolactone)–poly(ethylene oxide) diols and various chain extenders</article-title>. <source>J Biomed Mater Res</source> <year>2002</year>; <volume>60</volume>(<issue>4</issue>): <fpage>592</fpage>–<lpage>606</lpage>.</citation></ref>
<ref id="bibr8-0885328212448259"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohn</surname><given-names>D</given-names></name><name><surname>Stern</surname><given-names>T</given-names></name><name><surname>González</surname><given-names>MF</given-names></name><etal/></person-group>. <article-title>Biodegradable poly(ethylene oxide)/poly(ɛ-caprolactone) multiblock copolymers</article-title>. <source>J Biomed Mater Res</source> <year>2002</year>; <volume>59</volume>(<issue>2</issue>): <fpage>273</fpage>–<lpage>281</lpage>.</citation></ref>
<ref id="bibr9-0885328212448259"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saad</surname><given-names>GR</given-names></name><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Seliger</surname><given-names>H</given-names></name></person-group>. <article-title>Synthesis and characterization of biodegradable poly(ester-urethanes) based on bacterial poly(R-3-hydroxybutyrate)</article-title>. <source>J Appl Polym Sci</source> <year>2002</year>; <volume>83</volume>(<issue>4</issue>): <fpage>703</fpage>–<lpage>718</lpage>.</citation></ref>
<ref id="bibr10-0885328212448259"><label>10</label><citation citation-type="other"><comment>Gorna K and Gogolewski S. Novel biodegradable polyurethanes for medical applications. In: Agrawal CM, Parr JE and Lin ST (eds) <italic>Synthetic bioresorbable polymers for implants</italic>. ASTM Special Technical Publication. West Conshohocken, PA: American Society for Testing and Material. 2000, pp. 39–57</comment>.</citation></ref>
<ref id="bibr11-0885328212448259"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skarja</surname><given-names>GA</given-names></name><name><surname>Woodhouse</surname><given-names>KA</given-names></name></person-group>. <article-title>Structure-property relationships of degradable polyurethane elastomers containing an amino acid-based chain extender</article-title>. <source>J Appl Polym Sci</source> <year>2000</year>; <volume>75</volume>(<issue>12</issue>): <fpage>1522</fpage>–<lpage>1534</lpage>.</citation></ref>
<ref id="bibr12-0885328212448259"><label>12</label><citation citation-type="other"><comment>Woodhouse KA and Skarja GA. <italic>Biodegradable polyurethanes</italic>. Patent 6,221,997B1, USA, 2001</comment>.</citation></ref>
<ref id="bibr13-0885328212448259"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>J-C</given-names></name><name><surname>Klettlinger</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Blends of L-tyrosine based polyurethanes for biomaterial applications</article-title>. <source>eXPRESS Polym Lett</source> <year>2007</year>; <volume>1</volume>(<issue>11</issue>): <fpage>724</fpage>–<lpage>733</lpage>.</citation></ref>
<ref id="bibr14-0885328212448259"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marcos-Fernández</surname><given-names>A</given-names></name><name><surname>Abraham</surname><given-names>GA</given-names></name><name><surname>Valentín</surname><given-names>JL</given-names></name><etal/></person-group>. <article-title>Synthesis and characterization of biodegradable non-toxic poly(ester-urethane-urea)s based on poly(ɛ-caprolactone) and amino acid derivatives</article-title>. <source>Polymer</source> <year>2006</year>; <volume>47</volume>(<issue>3</issue>): <fpage>785</fpage>–<lpage>798</lpage>.</citation></ref>
<ref id="bibr15-0885328212448259"><label>15</label><citation citation-type="other"><comment>Gogolewski S. <italic>Biocompatible-biodegradable polyurethane materials with controlled hydrophobic to hydrophilic ratio</italic>. Patent 2008/0262613 A1, USA, 2008</comment>.</citation></ref>
<ref id="bibr16-0885328212448259"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Doll</surname><given-names>BA</given-names></name><name><surname>Beckman</surname><given-names>EJ</given-names></name><etal/></person-group>. <article-title>A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering</article-title>. <source>J Biomed Mater Res</source> <year>2003</year>; <volume>67A</volume>(<issue>2</issue>): <fpage>389</fpage>–<lpage>400</lpage>.</citation></ref>
<ref id="bibr17-0885328212448259"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan-Chan</surname><given-names>LH</given-names></name><name><surname>Solis-Correa</surname><given-names>R</given-names></name><name><surname>Vargas-Coronado</surname><given-names>RF</given-names></name><etal/></person-group>. <article-title>Degradation studies on segmented polyurethanes prepared with HMDI, PCL and different chain extenders</article-title>. <source>Acta Biomater</source> <year>2010</year>; <volume>6</volume>(<issue>6</issue>): <fpage>2035</fpage>–<lpage>2044</lpage>.</citation></ref>
<ref id="bibr18-0885328212448259"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poussard</surname><given-names>L</given-names></name><name><surname>Burel</surname><given-names>F</given-names></name><name><surname>Couvercelle</surname><given-names>JP</given-names></name><etal/></person-group>. <article-title>Hemocompatibility of new ionic polyurethanes: influence of carboxylic group insertion modes</article-title>. <source>Biomaterials</source> <year>2004</year>; <volume>25</volume>(<issue>17</issue>): <fpage>3473</fpage>–<lpage>3483</lpage>.</citation></ref>
<ref id="bibr19-0885328212448259"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Lewis</surname><given-names>RS</given-names></name></person-group>. <article-title>Improved haemocompatibility of cysteine-modified polymers via endogenous nitric oxide</article-title>. <source>Biomaterials</source> <year>2002</year>; <volume>23</volume>(<issue>4</issue>): <fpage>1197</fpage>–<lpage>1203</lpage>.</citation></ref>
<ref id="bibr20-0885328212448259"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frost</surname><given-names>MC</given-names></name><name><surname>Meyerhoff</surname><given-names>ME</given-names></name></person-group>. <article-title>Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles</article-title>. <source>J Biomed Mater Res</source> <year>2005</year>; <volume>72A</volume>(<issue>4</issue>): <fpage> 409</fpage>–<lpage>419</lpage>.</citation></ref>
<ref id="bibr21-0885328212448259"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>Y</given-names></name><name><surname>Nakao</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Endothelial cells on plasma-treated segmented-polyurethane: adhesion strength, antithrombogenicity and cultivation in tubes</article-title>. <source>J Mater Sci: Mater Med</source> <year>1997</year>; <volume>8</volume>(<issue>9</issue>): <fpage>551</fpage>–<lpage>557</lpage>.</citation></ref>
<ref id="bibr22-0885328212448259"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Özkucur</surname><given-names>N</given-names></name><name><surname>Richter</surname><given-names>E</given-names></name><name><surname>Wetzel</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Biological relevance of ion energy in performance of human endothelial cells on ion-implanted flexible polyurethane surfaces</article-title>. <source>J Biomed Mater Res</source> <year>2010</year>; <volume>93A</volume>(<issue>1</issue>): <fpage>258</fpage>–<lpage>268</lpage>.</citation></ref>
<ref id="bibr23-0885328212448259"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sidouni</surname><given-names>FZ</given-names></name><name><surname>Nurdin</surname><given-names>N</given-names></name><name><surname>Chabrecek</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Surface properties of a specifically modified high-grade medical polyurethane</article-title>. <source>Surf Sci</source> <year>2001</year>; <volume>491</volume>(<issue>3</issue>): <fpage>355</fpage>–<lpage>369</lpage>.</citation></ref>
<ref id="bibr24-0885328212448259"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>A novel strategy to graft RGD peptide on biomaterials surfaces for endothelization of small-diamater vascular grafts and tissue engineering blood vessel</article-title>. <source>J Mater Sci: Mater Med</source> <year>2008</year>; <volume>19</volume>(<issue>7</issue>): <fpage>2595</fpage>–<lpage>2603</lpage>.</citation></ref>
<ref id="bibr25-0885328212448259"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>S-h</given-names></name><name><surname>Sun</surname><given-names>S-h</given-names></name><name><surname>Chen</surname><given-names>DC</given-names></name></person-group>. <article-title>Improved retention of endothelial cells seeded on polyurethane small-diameter vascular grafts modified by a recombinant RGD-containing protein</article-title>. <source>Artif Organ</source> <year>2003</year>; <volume>27</volume>(<issue>12</issue>): <fpage>1068</fpage>–<lpage>1078</lpage>.</citation></ref>
<ref id="bibr26-0885328212448259"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>T-W</given-names></name><name><surname>Masters</surname><given-names>KS</given-names></name></person-group>. <article-title>Regulation of polyurethane hemocompatibility and endothelialization by tethered hyaluronic acid oligosaccharides</article-title>. <source>Biomaterials</source> <year>2009</year>; <volume>30</volume>(<issue>29</issue>): <fpage>5341</fpage>–<lpage>5351</lpage>.</citation></ref>
<ref id="bibr27-0885328212448259"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>T-W</given-names></name><name><surname>Liu</surname><given-names>D-Z</given-names></name><name><surname>Wang</surname><given-names>S-Y</given-names></name><etal/></person-group>. <article-title>Enhancement of the growth of human endothelial cells by surface roughness at nanometer scale</article-title>. <source>Biomaterials</source> <year>2003</year>; <volume>24</volume>(<issue>25</issue>): <fpage>4655</fpage>–<lpage>4661</lpage>.</citation></ref>
</ref-list>
</back>
</article>